Follow
Charles C Bell
Charles C Bell
Post doctoral researcher, Mater Research, University of Queensland
Verified email at mater.uq.edu.au
Title
Cited by
Cited by
Year
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
ML Burr, CE Sparbier, YC Chan, JC Williamson, K Woods, PA Beavis, ...
Nature 549 (7670), 101-105, 2017
7122017
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer
ML Burr, CE Sparbier, KL Chan, YC Chan, A Kersbergen, EYN Lam, ...
Cancer cell 36 (4), 385-401. e8, 2019
4002019
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
R Agarwal, YC Chan, CS Tam, T Hunter, D Vassiliadis, CE Teh, ...
Nature Medicine 25 (1), 119-129, 2019
1632019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
CC Bell, KA Fennell, YC Chan, F Rambow, MM Yeung, D Vassiliadis, ...
Nature communications 10 (1), 2723, 2019
1382019
Click chemistry enables preclinical evaluation of targeted epigenetic therapies
DS Tyler, J Vappiani, T Cañeque, EYN Lam, A Ward, O Gilan, YC Chan, ...
Science 356 (6345), 1397-1401, 2017
1272017
Principles and mechanisms of non-genetic resistance in cancer
CC Bell, O Gilan
British journal of cancer 122 (4), 465-472, 2020
1252020
A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing
CC Bell, GW Magor, KR Gillinder, AC Perkins
BMC genomics 15 (1), 1-7, 2014
1182014
KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome
GW Magor, MR Tallack, KR Gillinder, CC Bell, N McCallum, B Williams, ...
Blood, The Journal of the American Society of Hematology 125 (15), 2405-2417, 2015
932015
Interconversion between tumorigenic and differentiated states in acute myeloid leukemia
MD McKenzie, M Ghisi, EP Oxley, S Ngo, L Cimmino, C Esnault, R Liu, ...
Cell stem cell 25 (2), 258-272. e9, 2019
762019
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
AC Watt, P Cejas, MJ DeCristo, O Metzger-Filho, EYN Lam, X Qiu, ...
Nature cancer 2 (1), 34-48, 2021
532021
Direct targets of pSTAT5 signalling in erythropoiesis
KR Gillinder, H Tuckey, CC Bell, GW Magor, S Huang, MD Ilsley, ...
PLoS One 12 (7), e0180922, 2017
422017
Epigenetic therapies in acute myeloid leukemia: where to from here?
KA Fennell, CC Bell, MA Dawson
Blood, The Journal of the American Society of Hematology 134 (22), 1891-1901, 2019
392019
The Evx1/Evx1as gene locus regulates anterior-posterior patterning during gastrulation
CC Bell, PP Amaral, A Kalsbeek, GW Magor, KR Gillinder, P Tangermann, ...
Scientific reports 6 (1), 26657, 2016
312016
An Erg-driven transcriptional program controls B cell lymphopoiesis
AP Ng, HD Coughlan, S Hediyeh-Zadeh, K Behrens, TM Johanson, ...
Nature Communications 11 (1), 3013, 2020
302020
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes
CE Sparbier, A Gillespie, J Gomez, N Kumari, A Motazedian, KL Chan, ...
Nature cell biology 25 (2), 258-272, 2023
92023
Transcription factors use a unique combination of cofactors to potentiate different promoter-dependent steps in transcription
CC Bell, L Talarmain, L Scolamiero, EYN Lam, CS Ang, O Gilan, ...
bioRxiv, 2022.10. 25.513774, 2022
52022
TFIID and MYB Share a Therapeutic Handshake in AML
CC Bell, MA Dawson
Cancer Cell 33 (1), 1-3, 2018
32018
CRISPR–ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia
O Gilan, L Talarmain, CC Bell, D Neville, K Knezevic, DT Ferguson, ...
Nature Structural & Molecular Biology 30 (10), 1592-1606, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–18